The Lipid Droplet Protein DHRS3 Is a Regulator of Melanoma Cell State
Pigment Cell & Melanoma Research · 2025
DOI: 10.1111/pcmr.13208 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pigment Cell & Melanoma Research, 2025. Verfasst von Eleanor Johns und 8 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, New York, USA. Hauptthemen laut MEDLINE: Melanoma, Gene Expression Regulation, Neoplastic. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 102 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center, NIAMS NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
Lipid droplets are fat storage organelles composed of a protein envelope and lipid‐rich core. Regulation of this protein envelope underlies differential lipid droplet formation and function. In melanoma, lipid droplet formation has been linked to tumor progression and metastasis, but it is unknown whether lipid droplet proteins play a role. To address this, we performed proteomic analysis of the lipid droplet envelope in melanoma. We found that lipid droplet proteins were differentially enriched in distinct melanoma states; from melanocytic to undifferentiated. DHRS3, which converts all‐trans‐retinal to all‐trans‐retinol, is upregulated in the MITF LO /undifferentiated/neural crest‐like melanoma cell state and reduced in the MITF HI /melanocytic state. Increased DHRS3 expression is sufficient to drive MITF HI /melanocytic cells to a more undifferentiated/invasive state. These changes are due to retinoic acid‐mediated regulation of melanocytic genes. Our data demonstrate that melanoma cell state can be regulated by expression of lipid droplet proteins which affect downstream retinoid signaling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
- Gerstner Sloan Kettering Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
- Weill Cornell/Rockefeller/Sloan Kettering Tri-Institutional MD-PhD Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
- Cell and Developmental Biology Program, Weill Cornell Graduate School of Medical Sciences, New York, New York, USA.
- Ludwig Institute for Cancer Research, University of Oxford, Oxford, UK.
- The Proteomics Resource Center at the Rockefeller University, New York, New York, USA.
ORCID-Profile: Eleanor Johns, Pakavarin Louphrasitthiphol, Miranda V Hunter, Jeremy H Raymond, Colin R Goding, Richard M White
Förderung
- Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center
- NIAMS NIH HHS
- NIGMS NIH HHS
- NCI NIH HHS
- Harry J. Lloyd Charitable Trust
- NIH HHS
- Melanoma Research Alliance
- Pershing Square Foundation
Zitieren
APA
Johns, E., Ma, Y., Louphrasitthiphol, P., Peralta, C., Hunter, M. V., Raymond, J. H., Molina, H., Goding, C. R., & White, R. M. (2025). The Lipid Droplet Protein DHRS3 Is a Regulator of Melanoma Cell State. Pigment Cell & Melanoma Research. https://doi.org/10.1111/pcmr.13208
Vancouver
Johns E, Ma Y, Louphrasitthiphol P, Peralta C, Hunter MV, Raymond JH, et al. The Lipid Droplet Protein DHRS3 Is a Regulator of Melanoma Cell State. Pigment Cell & Melanoma Research. 2025. doi:10.1111/pcmr.13208
BibTeX
@article{Johns2025,
author = {Johns, Eleanor and Ma, Yilun and Louphrasitthiphol, Pakavarin and Peralta, Christopher and Hunter, Miranda V and Raymond, Jeremy H and Molina, Henrik and Goding, Colin R and White, Richard M},
title = {The Lipid Droplet Protein DHRS3 Is a Regulator of Melanoma Cell State},
journal = {Pigment Cell & Melanoma Research},
year = {2025},
doi = {10.1111/pcmr.13208}
}
EUVIMED